Open access
Oct 2026
mRNA-Based Therapy in Melanoma, Personalized Neoantigen Vaccines and the Future of Precision Immunotherapy
Improvements in both recurrence-free survival and distant metastasis-free survival for the combination of intismeran autogene and pembrolizumab compared with pembrolizumab alone are reported, representing an important milestone for mRNA-based cancer therapy.
Iliyan Pochileev
· Perspectivas en Ciencias Méd... · 0 citations